Takeda Pharmaceutical (TKPHF) Change in Intangibles (2018 - 2026)

Takeda Pharmaceutical's Change in Intangibles history runs 9 years deep, the most recent figure standing at -$107.9 million for Q1 2026.

• In Q1 2026, Change in Intangibles rose 62.52% year-over-year to -$107.9 million; the TTM figure through Mar 2026 stood at -$1.5 billion (down 61.15% YoY), while the FY2026 annual figure was -$1.6 billion, down 61.67% from the prior year.
• Change in Intangibles was -$107.9 million for Q1 2026 at Takeda Pharmaceutical, up from -$1.2 billion in the prior quarter.
• In the past five years, Change in Intangibles ranged from a high of -$75.1 million in Q3 2024 to a low of -$3.1 billion in Q1 2023.
• Historically, Change in Intangibles has averaged -$502.9 million across 5 years, with a median of -$187.7 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Change in Intangibles plunged 2108.38% in 2023, then jumped 95.67% in 2024.
• A 5-year view of Change in Intangibles shows it stood at -$121.5 million in 2022, then slumped by 67.35% to -$203.3 million in 2023, then soared by 62.58% to -$76.1 million in 2024, then slumped by 1421.71% to -$1.2 billion in 2025, then soared by 90.67% to -$107.9 million in 2026.
• The last three Change in Intangibles figures came in at -$107.9 million (Q1 2026), -$1.2 billion (Q4 2025), and -$86.4 million (Q3 2025), per Business Quant data.